Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response
Authors:
Posted in Papers / Human Studies|Original Research / November 16-30, 2025
J Headache Pain. 2025 Nov 28. doi: 10.1186/s10194-025-02239-1. Online ahead of print.
PMID: 41315923 | DOI: 10.1186/s10194-025-02239-1
Share this article
Sign Up For An MSC Newsletter
Register to Watch the MSC Emerging Science Contest!
The MSC Emerging Science Contest for Young Investigators will take place on Wednesday, December 13, 2023, from 8-10 PM Eastern (US) time. We welcome those who wish to watch the event as an attendee. Register here to attend, and learn more about the contest here.